JMP Securities has recently raised Sabra Health Care REIT Inc (SBRA) stock to Mkt Outperform rating, as announced on January 7, 2025, according to Finviz. Earlier, on December 5, 2024, Mizuho had ...

Health Care REITs LTC Properties (NYSE:LTC) and Sabra (NASDAQ:SBRA) were upgraded at JMP, citing multiple tailwinds are ...

Sabra Health Care REIT rated buy, undervalued compared to peers. Investment-grade ratings, +7% dividend yield opportunity.

Fintel reports that on January 7, 2025, JMP Securities upgraded their outlook for Sabra Health Care REIT (NasdaqGS:SBRA) from ...

Sabra Health Care REIT's balance sheet strengthened, with Moody's upgrading its outlook to positive. Read why SBRA stock is a ...

In a report released today, Aaron Hecht from JMP Securities upgraded Sabra Healthcare REIT (SBRA – Research Report) to a Buy, with a price ...

JMP Securities upgraded Sabra Health Care (SBRA) to Outperform from Market Perform with a $20 price target The firm expects “multiple ...

Jefferies lowered the firm’s price target on Sabra Health Care to $20 from $21 and keeps a Buy rating on the shares as part ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Jenny Van Leeuwen Harrington of Gilman Hill Asset Management picked Sabra Health Care REIT, Inc. as her final trade.

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...